Related Experiment Video
Updated: Jun 12, 2026

Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
[Acute coronary syndrome, a rare complication of human immunoglobulin therapy]
Rui Providência1, Jorge Fortuna, Alexandra Alves Pereira
1Serviço de Cardiologia, Centro Hospitalar de Coimbra, Portugal. rui_providencia@yahoo.com
Abstract:
Human immunoglobulin is being increasingly used in the treatment of autoimmune diseases. Despite being rare, thromboembolic complications like acute coronary syndrome (ACS) are possible and not reported in our country's literature. The authors present a case report of a 39 years old patient who developed an ACS after treatment of immune thrombocytopenic purpura with human immunoglobulin. A brief review of risk factors and mechanisms of this complication is performed.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Hypersensitivity Reactions: Immune-Complex Reactions
Humoral Immune Responses
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
